CPRX

Catalyst Pharmaceuticals (CPRX)

About Catalyst Pharmaceuticals (CPRX)

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Details

Daily high

$22.90

Daily low

$22.17

Price at open

$22.50

52 Week High

$24.27

52 Week Low

$13.12

Market cap

2.7B

Dividend yield

0.00%

Volume

653,567

Avg. volume

1.5M

P/E ratio

19.24

Catalyst Pharmaceuticals News